Related Experiment Video
Updated: Sep 26, 2025

05:53
Low-Cost Gait Analysis for Behavioral Phenotyping of Mouse Models of Neuromuscular Disease
Published on: July 18, 2019
16.9K
Freezing of Gait in Multiple System Atrophy
Huaguang Yang1, Weiyin Vivian Liu2, Shanshan Wang3
1Department of Radiology, Renmin Hospital of Wuhan University, Wuhan, China.
Frontiers in Aging Neuroscience
|April 25, 2022
Summary
Freezing of gait (FOG) affects over 65% of multiple system atrophy (MSA) patients, worsening with disease progression. This common FOG symptom in MSA is linked to reduced quality of life and cerebellar impairment.
Area of Science:
- Neurology
- Movement Disorders
- Clinical Research
Background:
- Freezing of gait (FOG) is a prevalent and debilitating gait disturbance in patients diagnosed with multiple system atrophy (MSA).
- Understanding the incidence and clinical correlates of FOG is crucial for managing MSA progression.
Purpose of the Study:
- To assess the incidence of Freezing of Gait (FOG) in a cohort of Chinese Multiple System Atrophy (MSA) patients.
- To identify clinical factors and disease characteristics associated with the presence of FOG in MSA.
Main Methods:
- A cross-sectional clinical study enrolled 99 patients with Multiple System Atrophy (MSA) from three hospitals.
- Data on FOG symptoms, disease duration, motor severity (UMSARS, SARA, H-Y stages), subtype, and medication (LDED) were collected and analyzed.
Main Results:
- 65.93% of the 91 analyzed MSA patients experienced FOG.
- FOG incidence correlated positively with disease duration, motor severity (UMSARS, SARA, H-Y stages), and MSA-cerebellum subtype.
- FOG was associated with lower quality of life scores, indicating a significant impact on patient well-being.
Conclusions:
- Freezing of Gait (FOG) is a common and significant clinical feature in Multiple System Atrophy (MSA) patients.
- FOG is associated with advanced disease, greater motor impairment, cerebellar involvement, and reduced quality of life in MSA.
- These findings highlight the importance of monitoring and managing FOG in MSA for improved patient outcomes.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
751
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
751
Parkinson's Disease: Treatment
411
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
411

